Results 161 to 170 of about 17,692,958 (217)

The challenge of HTLV-1 therapeutics: lessons from anti-protease approaches. [PDF]

open access: yesNew Microbes New Infect
Ahmadi Ghezeldasht S   +4 more
europepmc   +1 more source

The m<sup>6</sup>A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA. [PDF]

open access: yesJ Virol
Liang Y   +11 more
europepmc   +1 more source

Seroprevalence Assessment of HTLV-1 and Its Related Risk Factors in Patients With Rheumatoid Arthritis in Gonabad in 2023. [PDF]

open access: yesClin Med Insights Arthritis Musculoskelet Disord
Tehranian F   +3 more
europepmc   +1 more source

Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. [PDF]

open access: yesClin Infect Dis
Brites C   +8 more
europepmc   +1 more source

HTLV-1-Infected CD4<sup>+</sup> T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocyte Expansion in HAM/TSP. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Dozono M   +8 more
europepmc   +1 more source

Loss of HTLV-1-specific CD8<sup>+</sup> T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma. [PDF]

open access: yesBlood Neoplasia
Weterings DA   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy